Clinical trial
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in…
NCT00402506 · Medicure, Industry · Completed
Key facts
| NCT number | NCT00402506 |
|---|---|
| Title | A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG |
| Official title | MEND-CABG II: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG Surgery |
| Lead sponsor | Medicure, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Bypass Graft Surgery, Myocardial Ischemia, Reperfusion Injury |
| Intervention type | Drug |
| Interventions | (MC-1) Pyridoxal 5'-phosphate |
| Enrollment | 3,000 |
| Start date | Nov 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Nov 22, 2006 |
| Last update posted | Nov 16, 2007 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: